Rxi Pharmaceuticals (RXII) Stock Price & Overview

NASDAQ:RXII

Current stock price

0.33
0 (0%)
At close:
0.33
0 (0%)
After Hours:

The current stock price of RXII is 0.33 null. Today RXII is down by 0%. In the past month the price decreased by -25%. In the past year, price decreased by -44.07%.

RXII Key Statistics

52-Week Range0.31 - 6.76
Current RXII stock price positioned within its 52-week range.
1-Month Range0.31 - 0.5
Current RXII stock price positioned within its 1-month range.
Market Cap
1.445M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-3.30
Dividend Yield
N/A

RXII Stock Performance

Today
0%
1 Week
-23.26%
1 Month
-25.00%
3 Months
-78.43%
Longer-term
6 Months -87.21%
1 Year -44.07%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

RXII Stock Chart

Rxi Pharmaceuticals / RXII Daily stock chart

RXII Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to RXII. When comparing the yearly performance of all stocks, RXII is a bad performer in the overall market: 98.41% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RXII Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RXII. RXII may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RXII Earnings

Next Earnings DateN/A
Last Earnings DateN/A

RXII Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y63.1%
Revenue Next YearN/A

RXII Financial Highlights

Over the last trailing twelve months RXII reported a non-GAAP Earnings per Share(EPS) of -3.3000000000000003. The EPS increased by 74.39% compared to the year before.


Income Statements
Revenue(TTM)138.00K
Net Income(TTM)-7.63M
Industry RankSector Rank
PM (TTM) -5532.61%
ROA -200.45%
ROE -436.29%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%58.18%
Sales Q2Q%N/A
EPS 1Y (TTM)74.39%
Revenue 1Y (TTM)-21.05%

RXII Ownership

Ownership
Inst Owners9.91%
Shares4.38M
FloatN/A
Ins Owners789.55%
Short Float %N/A
Short RatioN/A

About RXII

Company Profile

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor. RXi Pharmaceuticals Corporation is based in Worcester, Massachusetts.

Company Info

Rxi Pharmaceuticals

257 SIMARANO DRIVE SUITE 101

MARLBOROUGH MA 01752

CEO: Geert Cauwenbergh

Phone: 508-767-3861

Rxi Pharmaceuticals / RXII FAQ

What does Rxi Pharmaceuticals do?

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor. RXi Pharmaceuticals Corporation is based in Worcester, Massachusetts.


What is the stock price of Rxi Pharmaceuticals today?

The current stock price of RXII is 0.33 null.


Does RXII stock pay dividends?

RXII does not pay a dividend.


What is the ChartMill technical and fundamental rating of RXII stock?

RXII has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of Rxi Pharmaceuticals (RXII) based on its PE ratio?

Rxi Pharmaceuticals (RXII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.3).